Used in research for treating cancers, particularly hematologic malignancies such as leukemia and lymphoma. Acts as a potent inhibitor of the MER receptor tyrosine kinase, which plays a role in tumor cell survival and immune evasion. Shows promise in preclinical studies by reducing tumor growth and enhancing anti-tumor immune responses. Investigated for its ability to cross the blood-brain barrier, making it a candidate for central nervous system malignancies. Also studied in combination with other agents to improve therapeutic efficacy.